Pneumonia Testing Market
Pneumonia Testing Market Forecasts to 2030 - Global Analysis By Product Type (Consumables & Reagents, Instruments, Analyzers and Other Product Types), Type (Streptococcus, Legionella, Chlamydophila, Viral Pneumonia, Mycoplasma Pneumonia and Other Types), Test Type, Method, Technology, End User and by Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $655.13 MN |
|
Projected Year Value (2030) |
US $1,122.77 MN |
|
CAGR (2023 - 2030) |
8.0% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Pneumonia Testing Market is accounted for $655.13 million in 2023 and is expected to reach $1,122.77 million by 2030 growing at a CAGR of 8.0% during the forecast period. A vital diagnostic procedure called pneumonia testing is used to determine whether pneumonia—a respiratory infection that inflames the lungs' air sacs—is present. Pneumonia is frequently caused by bacteria, viruses, or fungi. If treatment is not received, it can result in severe respiratory distress. Chest X-rays can be used to see abnormalities in the lungs; blood tests can determine whether an infection is present; and respiratory secretion analysis can pinpoint the cause.
According to a published article by the National Institutes of Health (NIH) in 2022, streptococcus pneumoniae accounts for up to 15.0% of pneumonia cases in the U.S. and 27.0% globally.
Market Dynamics:
Driver:
Population aging and contagious disease risk
One major factor driving the market for pneumonia testing is the demographic shift towards an aging population. There is an increased need for accurate testing procedures because elderly people are more vulnerable to respiratory infections, including pneumonia. Moreover, this demographic factor highlights early detection and the market's responsibility to meet the unique healthcare needs of the aging population.
Restraint:
High initial expenses for cutting-edge diagnostic systems
A barrier to the market for pneumonia testing is the upfront expenses linked to sophisticated diagnostic technologies. Modern instruments like sophisticated imaging technology and molecular diagnostics can be highly expensive up front. Additionally, this could slow down the market penetration of these cutting-edge testing techniques and restrict their adoption, especially in healthcare settings with limited resources.
Opportunity:
Development of platforms for multiplex testing
Pneumonia testing market opportunities are presented by the development of multiplex testing platforms, which can detect multiple pathogens simultaneously. By delivering thorough diagnostic data in a single test and expediting the diagnostic procedure, these platforms increase productivity. Furthermore, discovering co-infections and enhancing overall diagnostic accuracy are two areas in which multiplex testing is especially helpful.
Threat:
Financial limitations in healthcare systems
The widespread adoption of advanced pneumonia testing technologies is threatened by budgetary constraints in healthcare systems. Limited funds may make it more difficult to invest in healthcare personnel's training and to purchase cutting-edge diagnostic tools. Moreover, this may result in unequal access to cutting-edge testing techniques, which could compromise the overall efficacy of pneumonia diagnosis.
Covid-19 Impact:
The COVID-19 pandemic has changed dynamics and priorities in the healthcare sector, which has had a significant effect on the market for pneumonia tests. Pneumonia testing innovation has accelerated due to the pandemic's increased focus on respiratory health and the pressing need for diagnostic solutions. On the other hand, difficulties like supply chain disruptions, fluctuating healthcare spending, and the tremendous demand for testing resources at peak times have also presented formidable obstacles. Additionally, the pandemic has brought to light the critical role that scalable and effective pneumonia testing plays in international health emergencies, and this has forced the industry to innovate and adapt to the changing nature of infectious diseases.
The Viral Pneumonia segment is expected to be the largest during the forecast period
In terms of market share for pneumonia tests, the viral pneumonia segment is projected to hold the largest share. Viral pneumonia has received a lot of attention because of the prevalence of respiratory viruses like influenza and respiratory syncytial virus (RSV) as well as the COVID-19 pandemic, which was primarily caused by the novel coronavirus SARS-CoV-2. Molecular assays, antigen tests, and other diagnostic techniques have advanced as a result of the growth in demand for viral pneumonia-specific diagnostic solutions. Moreover, this segment has become a crucial focal point in the pneumonia testing market due to the contagious nature of respiratory viruses and the need for accurate and quick testing.
The Diagnostic Laboratories segment is expected to have the highest CAGR during the forecast period
In the market for pneumonia testing, the diagnostic laboratory segment is anticipated to grow at the highest CAGR. Diagnostic laboratories, which provide a variety of diagnostic modalities like imaging studies, blood tests, and molecular diagnostics, are essential to the provision of thorough and specialized testing services for pneumonia. Diagnostic laboratories have grown as a result of improvements in diagnostic technologies and the growing need for quick and accurate testing for pneumonia. Additionally, these facilities are frequently at the forefront of adopting cutting-edge diagnostic techniques and are outfitted to efficiently handle a high volume of tests.
Region with largest share:
The region of North America is projected to have the largest market share for pneumonia testing. The region's prominence is attributed to its strong healthcare infrastructure, cutting-edge diagnostic technologies, and proactive management of infectious diseases. Furthermore, the demand for pneumonia testing is driven by favorable reimbursement policies, heightened awareness, and a higher prevalence of respiratory infections in North America.
Region with highest CAGR:
In the market for pneumonia testing, the Asia-Pacific region is projected to have the highest CAGR. The rising incidence of respiratory infections, the aging population, the increased spending on healthcare infrastructure, and the increased emphasis on enhancing healthcare accessibility in Asia-Pacific nations are some of the causes of this. Moreover, the high growth is a result of the region's growing economies, improvements in healthcare technologies, and increased public awareness of the value of early diagnosis.
Key players in the market
Some of the key players in Pneumonia Testing market include Danaher , Abbott, F. Hoffmann-La Roche Ltd., Beckton and Dickinson Company, Cepheid, Biomerieux SA, Hologic Inc, Luminex Corporation, Meridian Bioscience, Inc., Bio Rad laboratories, OpGen, Quidel Corporation, AdvanDx, Thermo Fisher Scientific Inc., Beckman Coulter , Siemens Healthcare GmbH and Quest Diagnostics Incorporated.
Key Developments:
In September 2023, Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. Together, the companies have worked on connected diabetes solutions since 2017. Developed by Bigfoot Biomedical, Bigfoot Unity is a smart insulin management system. It features connected insulin pen caps that use integrated continuous glucose monitoring (iCGM) data and healthcare provider instructions.
In September 2023, Hologic and Bayer today announced an international partnership focused on improving breast cancer detection. The companies teamed up to deliver contrast-enhanced mammography (CEM) solutions across Europe, Canada and Asia Pacific. CEM, a highly sensitive, relatively low-cost breast imaging modality, combines digital mammography with contrast agent administration. It supports breast cancer diagnosis and guides treatment decisions.
In August 2023, Science and medical technology firm Danaher announced Monday that it has entered into an agreement to acquire Abcam, a Cambridge, U.K.-based supplier of antibodies, reagents, biomarkers, and assays. Under the agreement, Danaher will acquire all outstanding Abcam shares for $24 per share in cash, with a total enterprise value of approximately $5.7 billion, including Abcam’s assumed debts and net of acquired cash.
Product Types Covered:
• Consumables & Reagents
• Instruments
• Analyzers
• Other Product Types
Types Covered:
• Streptococcus
• Legionella
• Chlamydophila
• Viral Pneumonia
• Mycoplasma Pneumonia
• Other Types
Test Types Covered:
• Blood Test
• Imaging Test
• Sputum Test
• Urine Test
• Other Test Types
Methods Covered:
• Molecular Diagnostics
• Point of Care Testing
• Immunodiagnostics
• Other Methods
Technologies Covered:
• Enzyme Linked Immunosorbant Assay
• Immunofluoroscence
• Western Blot
• Polymerase Chain Reaction
• Imunohistochemistry
• Other Technologies
End Users Covered:
• Hospitals & Clinics
• Diagnostic Laboratories
• Homecare
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pneumonia Testing Market, By Product Type
5.1 Introduction
5.2 Consumables & Reagents
5.3 Instruments
5.4 Analyzers
5.5 Other Product Types
6 Global Pneumonia Testing Market, By Type
6.1 Introduction
6.2 Streptococcus
6.3 Legionella
6.4 Chlamydophila
6.5 Viral Pneumonia
6.6 Mycoplasma Pneumonia
6.7 Other Types
7 Global Pneumonia Testing Market, By Test Type
7.1 Introduction
7.2 Blood Test
7.3 Imaging Test
7.4 Sputum Test
7.5 Urine Test
7.6 Other Test Types
8 Global Pneumonia Testing Market, By Method
8.1 Introduction
8.2 Molecular Diagnostics
8.3 Point of Care Testing
8.4 Immunodiagnostics
8.5 Other Methods
9 Global Pneumonia Testing Market, By Technology
9.1 Introduction
9.2 Enzyme Linked Immunosorbant Assay
9.3 Immunofluoroscence
9.4 Western Blot
9.5 Polymerase Chain Reaction
9.6 Imunohistochemistry
9.7 Other Technologies
10 Global Pneumonia Testing Market, By End User
10.1 Introduction
10.2 Hospitals & Clinics
10.3 Diagnostic Laboratories
10.4 Homecare
10.5 Other End Users
11 Global Pneumonia Testing Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Danaher
13.2 Abbott
13.3 F. Hoffmann-La Roche Ltd.
13.4 Beckton and Dickinson Company
13.5 Cepheid
13.6 Biomerieux SA
13.7 Hologic Inc
13.8 Luminex Corporation
13.9 Meridian Bioscience, Inc.
13.10 Bio Rad laboratories
13.11 OpGen
13.12 Quidel Corporation
13.13 AdvanDx
13.14 Thermo Fisher Scientific Inc.
13.15 Beckman Coulter
13.16 Siemens Healthcare GmbH
13.17 Quest Diagnostics Incorporated
List of Tables
1 Global Pneumonia Testing Market Outlook, By Region (2021-2030) ($MN)
2 Global Pneumonia Testing Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Pneumonia Testing Market Outlook, By Consumables & Reagents (2021-2030) ($MN)
4 Global Pneumonia Testing Market Outlook, By Instruments (2021-2030) ($MN)
5 Global Pneumonia Testing Market Outlook, By Analyzers (2021-2030) ($MN)
6 Global Pneumonia Testing Market Outlook, By Other Product Types (2021-2030) ($MN)
7 Global Pneumonia Testing Market Outlook, By Type (2021-2030) ($MN)
8 Global Pneumonia Testing Market Outlook, By Streptococcus (2021-2030) ($MN)
9 Global Pneumonia Testing Market Outlook, By Legionella (2021-2030) ($MN)
10 Global Pneumonia Testing Market Outlook, By Chlamydophila (2021-2030) ($MN)
11 Global Pneumonia Testing Market Outlook, By Viral Pneumonia (2021-2030) ($MN)
12 Global Pneumonia Testing Market Outlook, By Mycoplasma Pneumonia (2021-2030) ($MN)
13 Global Pneumonia Testing Market Outlook, By Other Types (2021-2030) ($MN)
14 Global Pneumonia Testing Market Outlook, By Test Type (2021-2030) ($MN)
15 Global Pneumonia Testing Market Outlook, By Blood Test (2021-2030) ($MN)
16 Global Pneumonia Testing Market Outlook, By Imaging Test (2021-2030) ($MN)
17 Global Pneumonia Testing Market Outlook, By Sputum Test (2021-2030) ($MN)
18 Global Pneumonia Testing Market Outlook, By Urine Test (2021-2030) ($MN)
19 Global Pneumonia Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
20 Global Pneumonia Testing Market Outlook, By Method (2021-2030) ($MN)
21 Global Pneumonia Testing Market Outlook, By Molecular Diagnostics (2021-2030) ($MN)
22 Global Pneumonia Testing Market Outlook, By Point of Care Testing (2021-2030) ($MN)
23 Global Pneumonia Testing Market Outlook, By Immunodiagnostics (2021-2030) ($MN)
24 Global Pneumonia Testing Market Outlook, By Other Methods (2021-2030) ($MN)
25 Global Pneumonia Testing Market Outlook, By Technology (2021-2030) ($MN)
26 Global Pneumonia Testing Market Outlook, By Enzyme Linked Immunosorbant Assay (2021-2030) ($MN)
27 Global Pneumonia Testing Market Outlook, By Immunofluoroscence (2021-2030) ($MN)
28 Global Pneumonia Testing Market Outlook, By Western Blot (2021-2030) ($MN)
29 Global Pneumonia Testing Market Outlook, By Polymerase Chain Reaction (2021-2030) ($MN)
30 Global Pneumonia Testing Market Outlook, By Imunohistochemistry (2021-2030) ($MN)
31 Global Pneumonia Testing Market Outlook, By Other Technologies (2021-2030) ($MN)
32 Global Pneumonia Testing Market Outlook, By End User (2021-2030) ($MN)
33 Global Pneumonia Testing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
34 Global Pneumonia Testing Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
35 Global Pneumonia Testing Market Outlook, By Homecare (2021-2030) ($MN)
36 Global Pneumonia Testing Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
